No Data
Weight-reducing version of semaglutide lands in the Chinese market! Novo Nordisk (NVO.US) unlocks new growth engine.
novo-nordisk a/s launched Wegovy in china at a price lower than in the usa; this is an important step for the company to increase its investment in the rapidly growing market in china.
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Top Midday Stories: Spirit Airlines Files for Chapter 11 Bankruptcy Protection; Trump Team Looking to Ease Rules for Self-Driving Cars
European Equities Traded in the US as American Depositary Rise in Monday Trading
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA